Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $385.6550 (-1.35%) ($385.6550 - $385.6550) on Thu. Jan. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.53% (three month average) | RSI | 62 | Latest Price | $385.6550(-1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.765% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-5%) TIP(-1%) UUP(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.765% (StdDev 1.53%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $385.01(0.17%) | 10 Day Moving Average | $380.91(1.25%) | 20 Day Moving Average | $377.61(2.13%) | To recent high | -1.3% | To recent low | 29.4% | Market Cap | $40.89b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |